Search hospitals > North Carolina > Raleigh
WakeMed
Claim this profileRaleigh, North Carolina 27610
Global Leader in Coronary Artery Disease
Global Leader in Heart Failure
Conducts research for Myocardial Ischemia
Conducts research for Coronary Heart Disease
Conducts research for Atherosclerosis
92 reported clinical trials
9 medical researchers
Summary
WakeMed is a medical facility located in Raleigh, North Carolina. This center is recognized for care of Coronary Artery Disease, Heart Failure, Myocardial Ischemia, Coronary Heart Disease, Atherosclerosis and other specialties. WakeMed is involved with conducting 92 clinical trials across 113 conditions. There are 9 research doctors associated with this hospital, such as Judson B Williams, MD, Frances Wood, MD, Saroj Neupane, MD, and Stephen Kicklighter, MD.Top PIs
Judson B Williams, MDWakeMed1 year of reported clinical research
Studies Stroke
Studies Atrial Fibrillation
3 reported clinical trials
4 drugs studied
Frances Wood, MDWakeMed Hospital7 years of reported clinical research
Studies Heart Attack
Studies Heart Failure
3 reported clinical trials
4 drugs studied
Saroj Neupane, MDWake Medical Center3 years of reported clinical research
Studies Stent Restenosis
1 reported clinical trial
2 drugs studied
Stephen Kicklighter, MDWakeMed Health and Hospitals6 years of reported clinical research
Studies Bronchopulmonary Dysplasia
1 reported clinical trial
2 drugs studied
Clinical Trials running at WakeMed
Stroke
Kidney Failure
Lung Cancer
Chronic Kidney Disease
Bleeding
Atrial Fibrillation
Infections
Endotracheal Intubation
Infants
Embolism
Anticoagulation + Antiplatelet Therapy
for Post-Operative Atrial Fibrillation
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their baseline risk profile and their treatment strategy in terms of anticoagulants or antiplatelets received. These patients will also be asked to fill out a brief decliner survey.
Recruiting2 awards Phase 32 criteria
Left Atrial Appendage Exclusion
for Stroke Prevention
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Recruiting1 award N/A2 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at WakeMed?
WakeMed is a medical facility located in Raleigh, North Carolina. This center is recognized for care of Coronary Artery Disease, Heart Failure, Myocardial Ischemia, Coronary Heart Disease, Atherosclerosis and other specialties. WakeMed is involved with conducting 92 clinical trials across 113 conditions. There are 9 research doctors associated with this hospital, such as Judson B Williams, MD, Frances Wood, MD, Saroj Neupane, MD, and Stephen Kicklighter, MD.